Intracoronary KAI-9803 for Injection as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction

Trial Profile

Intracoronary KAI-9803 for Injection as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Sep 2011

At a glance

  • Drugs Delcasertib (Primary)
  • Indications Acute coronary syndromes; Myocardial infarction; Myocardial reperfusion injury
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms DELTA MI
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Mar 2007 Results data have been reported.
    • 26 Mar 2007 Status changed from "in progress" to "completed".
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top